Only 4.5 percent often or always discuss these experiences with colleagues; discussion linked to lower odds of burnout ...

Sonu, an AI-enabled wearable device, is now approved for use in pediatric patients aged 12 years and older for the relief of moderate to severe nasal ...

In 2022, the Biden administration issued the existing directive to hospitals in an effort to preserve abortion access for extreme cases in which women were experiencing medical emergencies and needed ...

HealthDay News — A 1-unit increase in lead levels is associated with worse academic performance throughout school grades, according to a study published online May 28 in JAMA Network Open.

HealthDay News — A federal judge has ruled that transgender inmates in US prisons must continue getting medical care, including hormone therapy and gender-affirming accommodations.

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

The approval was supported by data from 2 randomized, double-blind, vehicle-controlled trials that included 736 patients aged 12 years and older with mild to severe plaque psoriasis of the scalp and ...

The approval was supported by data from the randomized, double-blind, placebo-controlled, phase 3 ARANOTE trial.

Arakoda, an 8-aminoquinolone antimalarial, was approved in 2018 for the prophylaxis of malaria in patients aged 18 years and older.

Findings seen in women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for HR-positive breast cancer.

It's not likely that shoppers will come across any fresh tomatoes from the recalled batch, according to the FDA.

Zoryve (roflumilast) topical foam, 0.3% Phosphodiesterase type 4 inhibitor Treatment of plaque psoriasis of the scalp and body in adult and pediatric patients aged 12 years and older. Zoryve Foam ...